← Leaderboards
Mark E Glickman
Boston University
$359,617
Attributed
$359,617
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $185K · FY2014–15$200K$150K$100K$50K$0
'14
'15
Funding mix
By agency
NIH$269,082 · 2
AHRQ$90,535 · 1
By mechanism
R21$187,582 · 1
R03$172,035 · 2
Top collaborators
No co-investigators on record.
Most similar at Boston University
Same institution · by research overlap
- Merrill F Elias$5,777,902
- Carlo J De Luca$11,704,800
- H.eugene Eugene Stanley$4,956,070
- Joshua D Berke$16,196,666
- Dean R. Tolan$2,772,110
Others in their field
Top investigators on “Accounting”
- Gary D Acton · University Of California-Davis$320,373,312
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$185,928,938
- Zeljko Ivezic · University Of Washington$142,654,512
- Victor Krabbendam · Association Of Universities For Research In Astronomy, Inc.$142,654,512
- Steven M Kahn · Association Of Universities For Research In Astronomy, Inc.$142,654,512
Research focus
AccountingAdherence (Attribute)AdultAfrican AmericanAgingAmericanAntihypertensive AgentsApolipoprotein EAreaBaseBehaviorBlood PressureBlood Pressure RegulationCardiovascular DiseasesCardiovascular DisorderCardiovascular Disorder EpidemiologyClinical ResearchCohortComparative EffectivenessComplexCompliance BehaviorComputer SimulationDemographic Factors20 Year Old
Grant awards (5)
ASSESSING THE EFFECTS OF ANTIHYPERTENSIVE MEDICATION ADHERENCE THROUGH BAYESIAN D$93,082
R21 · FY2015 · HL · contact PI
ASSESSING THE EFFECTS OF ANTIHYPERTENSIVE MEDICATION ADHERENCE THROUGH BAYESIAN D$94,500
R21 · FY2014 · HL · contact PI
Measuring Effects of Antihypertensive Medication Adherence on BP levels through B$58,167
R03 · FY2014 · HS · contact PI
Measuring Effects of Antihypertensive Medication Adherence on BP levels through B$32,368
R03 · FY2014 · HS · contact PI
Modeling the Effects of Apo-E Genotypes on CVD Onset Age$81,500
R03 · FY2001 · AG